Details
Stereochemistry | ACHIRAL |
Molecular Formula | C23H23FN4O2 |
Molecular Weight | 406.4527 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
FC1=C(C=C(CC2=NNC(=O)C3=CC=CC=C23)C=C1)C(=O)N4CC(CNC5CC5)C4
InChI
InChIKey=YNBQAYKYNYRCCA-UHFFFAOYSA-N
InChI=1S/C23H23FN4O2/c24-20-8-5-14(10-21-17-3-1-2-4-18(17)22(29)27-26-21)9-19(20)23(30)28-12-15(13-28)11-25-16-6-7-16/h1-5,8-9,15-16,25H,6-7,10-13H2,(H,27,29)
Molecular Formula | C23H23FN4O2 |
Molecular Weight | 406.4527 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:10:49 GMT 2023
by
admin
on
Sat Dec 16 16:10:49 GMT 2023
|
Record UNII |
PUP792O0IW
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
816221
Created by
admin on Sat Dec 16 16:10:49 GMT 2023 , Edited by admin on Sat Dec 16 16:10:49 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
11225
Created by
admin on Sat Dec 16 16:10:49 GMT 2023 , Edited by admin on Sat Dec 16 16:10:49 GMT 2023
|
PRIMARY | |||
|
PUP792O0IW
Created by
admin on Sat Dec 16 16:10:49 GMT 2023 , Edited by admin on Sat Dec 16 16:10:49 GMT 2023
|
PRIMARY | |||
|
1681017-83-3
Created by
admin on Sat Dec 16 16:10:49 GMT 2023 , Edited by admin on Sat Dec 16 16:10:49 GMT 2023
|
PRIMARY | |||
|
117955898
Created by
admin on Sat Dec 16 16:10:49 GMT 2023 , Edited by admin on Sat Dec 16 16:10:49 GMT 2023
|
PRIMARY | |||
|
300000027584
Created by
admin on Sat Dec 16 16:10:49 GMT 2023 , Edited by admin on Sat Dec 16 16:10:49 GMT 2023
|
PRIMARY | |||
|
C175871
Created by
admin on Sat Dec 16 16:10:49 GMT 2023 , Edited by admin on Sat Dec 16 16:10:49 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
antineoplastic
|